Researchers at the University of Michigan have had initial success in mice using nanodiscs to deliver a customized therapeutic vaccine for the treatment of colon and melanoma cancer tumors.
“We are basically educating the immune system with these nanodiscs so that immune cells can attack cancer cells in a personalized manner,” said James Moon, the John Gideon Searle assistant professor of pharmaceutical sciences and biomedical engineering.
Personalized immunotherapy is a fast-growing field of research in the fight against cancer.
The therapeutic cancer vaccine employs nanodiscs loaded with tumor neoantigens, which are unique mutations found in tumor cells. By generating T-cells that recognize these specific neoantigens, the technology targets cancer mutations and fights to eliminate cancer cells and prevent tumor growth.
Unlike preventive vaccinations, therapeutic cancer vaccines of this type are meant to kill established cancer cells.
“The idea is that these vaccine nanodiscs will trigger the immune system to fight the existing cancer cells in a personalized manner,” Moon said.
The nanodisc technology was tested in mice with established melanoma and colon cancer tumors. After the vaccination, twenty-seven percent of T-cells in the blood of the mice in the study targeted the tumors.
When combined with immune checkpoint inhibitors, an existing technology that amplifies T-cell tumor-fighting responses, the nanodisc technology killed tumors within 10 days of treatment in the majority of the mice. After waiting 70 days, researchers then injected the same mice with the same tumor cells, and the tumors were rejected by the immune system and did not grow.
“This suggests the immune system ‘remembered’ the cancer cells for long-term immunity,” said Rui Kuai, U-M doctoral student in pharmaceutical sciences and lead author of the study.
“The holy grail in cancer immunotherapy is to eradicate tumors and prevent future recurrence without systemic toxicity, and our studies have produced very promising results in mice,” Moon said.
The technology is made of extremely small, synthetic high density lipoproteins measuring roughly 10 nanometers. By comparison, a human hair is 80,000 to 100,000 nanometers wide.
“It’s a powerful vaccine technology that efficiently delivers vaccine components to the right cells in the right tissues. Better delivery translates to better T-cell responses and better efficacy,” said study co-senior author Anna Schwendeman, U-M assistant professor of pharmacy.
The next step is to test the nanodisc technology in a larger group of larger animals, Moon said.
Learn more: Nanodiscs deliver personalized cancer therapy to immune system
[osd_subscribe categories=’personalized-immunotherapy’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “PERSONALIZED IMMUNOTHERAPY”‘]
Receive an email update when we add a new PERSONALIZED IMMUNOTHERAPY article.
The Latest on: Personalized immunotherapy
[google_news title=”” keyword=”personalized immunotherapy” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Personalized immunotherapy
- Vitamin D Alters Gut Bacteria for Enhanced Cancer Immunityon April 27, 2024 at 9:42 am
Vitamin D regulates microbiome-dependent cancer immunity - (https://www.science.org/doi/10.1126/science.adh7954) ...
- Medical Bulletin 27/ April/ 2024on April 27, 2024 at 2:30 am
Can cancer vaccine with immunotherapy shrink liver tumor?According to a study published in the journal Nature Medicine, people with ...
- Can cancer vaccine with immunotherapy shrink liver tumor?on April 26, 2024 at 7:30 pm
According to a study published in the journal Nature Medicine, people with Hepatocellular Carcinoma treated with immunotherapy and a personalized anti-tumor vaccine were twice as likely to experience ...
- U.K. Tests World-First Personalized Skin Cancer Vaccineon April 26, 2024 at 9:08 am
Customized with genetic information from a patient’s own tumor, vaccines like this could one day be used against lung, kidney, bladder and colon cancer.
- World’s 1st skin cancer vaccine enters final trial, offers personalized cureon April 26, 2024 at 8:07 am
Scientists are testing the world's first skin cancer vaccine, which has entered global trial. They aim for personalized treatment.
- Headline: UK cancer patient pioneers groundbreaking skin cancer vaccine trialon April 26, 2024 at 5:16 am
A novel immunotherapy trial, using mRNA technology like in COVID vaccines, aims to prevent skin cancer recurrence. The trial combines a personalized mRNA vaccine with Keytruda, blocking an immune ...
- New Clinical Study Identifies Personalized Treatment Options for Metastatic Non-Small Cell Lung Cancer With Plasma Proteome Testingon April 25, 2024 at 7:40 am
Florida Cancer Specialists & Research Institute, LLC (FCS) medical oncologist and hematologist Ernesto Bustinza-Linares, MD is co-author of a recent abstract published in the American Society of ...
- AI could predict whether cancer treatments will work, experts say: ‘Exciting time in medicine'on April 23, 2024 at 3:00 am
A chemotherapy alternative called immunotherapy is showing promise in treating cancer — and a new artificial intelligence tool could help ensure that patients have the best possible experience.
- Immunotherapy Regenerative Medicine Clinic on Using Stem Cells to Activate the Body's Natural Healing Poweron April 18, 2024 at 10:02 am
Stem cell therapy, a cornerstone of regenerative medicine, has shown immense potential in treating autoimmune diseases, aging conditions, and ...
via Bing News